All locations
| Company | Sector & Purpose | Updated | Following |
|---|---|---|---|
Takeda Pharmaceutical Company
|
Biopharmaceuticals
Better health for people worldwide through leading innovation in medicine
|
2025-Q3
|
|
Merck
|
Biopharmaceuticals
To discover, develop and provide innovative products and services that save and improve lives around the world
|
2025-Q3
|
|
Pfizer
|
Biopharmaceuticals
To discover, develop and deliver breakthrough medicines and vaccines that help patients live longer, healthier lives
|
2025-Q3
|
|
Eli Lilly
|
Biopharmaceutical
To make life better for people around the world through medicines that matter
|
2025-Q3
|
|
Novo Nordisk
|
Pharmaceutical
To drive change to defeat diabetes and other serious chronic diseases
|
2025-Q3
|
|
Gilead Sciences
|
Biopharmaceutical
To advance the care of patients suffering from life-threatening diseases
|
2025-Q3
|
|
Haleon
|
Consumer Healthcare
To deliver better everyday health with humanity by improving access to healthcare and wellness solutions globally
|
2025-Q3
|
|
Apellis Pharmaceuticals
|
Biopharmaceutical
To develop and commercialize innovative therapies that harness the power of targeted complement inhibition to treat patients with serious diseases
|
2025-Q3
|
|
Aquestive Therapeutics
|
Specialty Pharmaceuticals
To transform lives through innovative pharmaceutical solutions that improve patient outcomes and quality of life
|
2025-Q3
|
|
Johnson & Johnson
|
Healthcare
To blend heart, science and ingenuity to profoundly change the trajectory of health for humanity
|
2025-Q2
|
|
Kenvue
|
Consumer Health
To realize the extraordinary power of everyday care by creating products that help people feel good, look good, and live better
|
2025-Q3
|
|
Arbutus Biopharma
|
Biotechnology
To discover, develop and commercialize a cure for patients suffering from chronic hepatitis B virus infection
|
2025-Q3
|
|
Otsuka
|
Pharmaceuticals
To improve health worldwide and create innovative products.
|
2025-Q3
|
|
Belief Biomed
|
Biotech
To develop breakthrough therapeutics for rare diseases using innovative AI-driven drug discovery platforms
|
2025-Q3
|
Page 2 of 2
Showing 21 to 34 of 34 analyses